Erste Group analyst Hans Engel upgrades Merck & Co (NYSE:MRK) from Hold to Buy.
Analyst Ratings for F5
Within the last quarter, F5 (NASDAQ:FFIV) has observed the following analyst ratings:
Erste Group Upgrades Merck & Co to Buy
Erste Group analyst Hans Engel upgrades Merck & Co (NYSE:MRK) from Hold to Buy.
Related Posts
6 Analysts Have This to Say About SmartRent
Over the past 3 months, 6 analysts have published their opinion on SmartRent (NYSE:SMRT) stock. These analysts are…
Stifel Reinstates Buy on IPG Photonics, Announces $110 Price Target
Stifel analyst Ruben Roy reinstates IPG Photonics (NASDAQ:IPGP) with a Buy and announces $110 price target.
BASF’s Leadership Shakeup: What’s Next Under New Chairman Dr. Markus Kamieth?
BASF SE (OTC: BFFAF) (OTC: BASFY) announced that Dr. Markus Kamieth (53) will take over as Chairman of the Board of Executive Directors, effective after the annual meeting on April 25, 2024.